T. Rowe Price Associates’s NeuBase Therapeutics, Inc. Common Stock NBSE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-617
| Closed | -$94K | – | 2725 |
|
|
2020
Q3 | $94K | Buy |
+617
| New | +$94K | ﹤0.01% | 2507 |
|
|
2017
Q2 | – | Sell |
-67
| Closed | -$22K | – | 2583 |
|
|
2017
Q1 | $22K | Hold |
67
| – | – | ﹤0.01% | 2561 |
|
|
2016
Q4 | $40K | Hold |
67
| – | – | ﹤0.01% | 2534 |
|
|
2016
Q3 | $76K | Hold |
67
| – | – | ﹤0.01% | 2471 |
|
|
2016
Q2 | $73K | Hold |
67
| – | – | ﹤0.01% | 2460 |
|
|
2016
Q1 | $86K | Hold |
67
| – | – | ﹤0.01% | 2426 |
|
|
2015
Q4 | $164K | Buy |
67
+38
| +131% | +$93K | ﹤0.01% | 2343 |
|
|
2015
Q3 | $32K | Hold |
29
| – | – | ﹤0.01% | 2489 |
|
|
2015
Q2 | $29K | Hold |
29
| – | – | ﹤0.01% | 2518 |
|
|
2015
Q1 | $30K | Sell |
29
-4
| -12% | -$4.14K | ﹤0.01% | 2524 |
|
|
2014
Q4 | $108K | Sell |
33
-3
| -8% | -$9.82K | ﹤0.01% | 2462 |
|
|
2014
Q3 | $103K | Hold |
36
| – | – | ﹤0.01% | 2468 |
|
|
2014
Q2 | $135K | Buy |
36
+8
| +29% | +$30K | ﹤0.01% | 2435 |
|
|
2014
Q1 | $152K | Hold |
28
| – | – | ﹤0.01% | 2376 |
|
|
2013
Q4 | $88K | Buy |
+28
| New | +$88K | ﹤0.01% | 2416 |
|